middle.news
Why Are Botanix’s Sofdra Sales Surging 28% This Quarter?
8:34am on Tuesday 27th of January, 2026 AEDT
•
Healthcare
Read Story
Why Are Botanix’s Sofdra Sales Surging 28% This Quarter?
8:34am on Tuesday 27th of January, 2026 AEDT
Key Points
Sofdra net revenue up 28% to $9.1 million in Q2 FY26
Total prescriptions shipped increased 24% quarter-on-quarter
Operating cash outflow rose due to 23 new sales hires and start-up costs
Strong market acceptance with 90% of healthcare professionals planning increased prescribing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Botanix Pharmaceuticals (ASX:BOT)
OPEN ARTICLE